1. Home
  2. KEQU vs VRCA Comparison

KEQU vs VRCA Comparison

Compare KEQU & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

HOLD

Current Price

$35.62

Market Cap

110.9M

Sector

Industrials

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$5.35

Market Cap

107.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
VRCA
Founded
1906
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.9M
107.5M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
KEQU
VRCA
Price
$35.62
$5.35
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
4.4K
25.1K
Earning Date
03-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.22
N/A
Revenue
$138,558,000.00
$35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$94.44
P/E Ratio
$11.18
N/A
Revenue Growth
7.72
370.22
52 Week Low
$33.27
$3.28
52 Week High
$60.89
$9.82

Technical Indicators

Market Signals
Indicator
KEQU
VRCA
Relative Strength Index (RSI) 48.43 41.63
Support Level $35.15 $5.32
Resistance Level $41.25 $6.53
Average True Range (ATR) 0.99 0.40
MACD -0.00 -0.08
Stochastic Oscillator 28.20 17.23

Price Performance

Historical Comparison
KEQU
VRCA

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: